Common Stock SEC Reporting - Current
OTCQX International OTCQX Advisor: Dorsey & Whitney LLP
Contact Info
  • Suite 210
  • 1167 Kensington Crescent NW
  • Calgary, ALB T2N 1X7
  • Canada

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2015 20-F
CIK 0001129928
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Canada
Year of Inc. Not Available
Employees 22 a/o Dec 31, 2014
Company Officers/Contacts
Brad Thompson CEO
Matt Coffey COO
Kirk Look CFO
George Gill Senior VP
Allan Tuchman Senior VP
Allan Warrander Business Development
Company Directors
Wayne Pisano Chairman
Matt Coffey
Angela Holtham
John Mark Lievonen
William G. Rice
Robert Schultz
Bernd R. Seizinger
Brad Thompson
Service Providers
OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202

Accounting/Auditing Firm
Ernst & Young LLP
440 2 Ave SW
Calgary, ALB, T2P 5E9

Legal Counsel
McCarthy Tetrault LLP
Suite 3300
421 7th Ave SW
Calgary, ALB, T2P 4K9

Investor Relations Firm
National Equicom
800 - 6 Avenue SW
Calgary, ALB, T2P 3G3

ONCYF Security Details
Share Structure
Market Value1 $20,048,177 a/o Dec 07, 2016
Authorized Shares Unlimited a/o Apr 29, 2016
Outstanding Shares 119,562,122 a/o Apr 29, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 116,825,362 a/o Oct 14, 2015
Par Value No Par Value
Shareholders of Record 191 a/o Mar 06, 2009
Non US Stock Exchange Listing
ONC - Toronto Stock Exchange - Qualified
Short Selling Data
Short Interest 17,665 (-61.26%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security